Cumberland Pharmaceuticals, Inc. (CPIX)
6.66
+0.86
(+14.83%)
USD |
NASDAQ |
Nov 18, 16:00
6.55
-0.11
(-1.65%)
After-Hours: 20:00
Cumberland Pharmaceuticals Gross Profit Margin (Quarterly) : 49.33% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 49.33% |
| June 30, 2026 | |
| March 31, 2026 | 64.84% |
| December 31, 2025 | 76.00% |
| September 30, 2025 | -52.62% |
| June 30, 2025 | |
| March 31, 2025 | 79.02% |
| December 31, 2024 | 66.72% |
| September 30, 2024 | 73.16% |
| June 30, 2024 | 71.06% |
| March 31, 2024 | 67.92% |
| December 31, 2023 | 70.46% |
| September 30, 2023 | 70.14% |
| June 30, 2023 | 75.00% |
| March 31, 2023 | 72.83% |
| December 31, 2022 | 65.35% |
| September 30, 2022 | 66.98% |
| June 30, 2022 | 64.56% |
| March 31, 2022 | 65.41% |
| December 31, 2021 | 47.09% |
| September 30, 2021 | 70.25% |
| June 30, 2021 | 67.22% |
| March 31, 2021 | 65.41% |
| December 31, 2020 | 65.99% |
| September 30, 2020 | 63.97% |
| Date | Value |
|---|---|
| June 30, 2020 | 60.49% |
| March 31, 2020 | 66.56% |
| December 31, 2019 | 62.23% |
| September 30, 2019 | 61.28% |
| June 30, 2019 | 69.31% |
| March 31, 2019 | 68.67% |
| December 31, 2018 | 72.28% |
| September 30, 2018 | 74.40% |
| June 30, 2018 | 78.11% |
| March 31, 2018 | 74.14% |
| December 31, 2017 | 75.73% |
| September 30, 2017 | 74.76% |
| June 30, 2017 | 73.21% |
| March 31, 2017 | 78.80% |
| December 31, 2016 | 75.58% |
| September 30, 2016 | 70.57% |
| June 30, 2016 | 76.47% |
| March 31, 2016 | 76.66% |
| December 31, 2015 | 73.15% |
| September 30, 2015 | 80.79% |
| June 30, 2015 | 79.59% |
| March 31, 2015 | 80.16% |
| December 31, 2014 | 78.92% |
| September 30, 2014 | 80.23% |
| June 30, 2014 | 82.52% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 54.92% |
| Corcept Therapeutics, Inc. | 98.65% |
| Veru, Inc. | -- |
| Johnson & Johnson | 68.11% |
| Eli Lilly & Co. | 83.88% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -27.78% |
| Return on Assets | -11.45% |
| Return on Invested Capital | -22.27% |
| Profit Margin (Quarterly) | -52.04% |
| Operating Margin (Quarterly) | -89.80% |
| Return on Net Operating Assets | -25.12% |